$PMDI
PSYCHEMEDICS CORP Stock $pmdi

$pmdi Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000117184322002192 Filed on March 30, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$6.436M	$24.91M	$5.335M
YoY Change	20.64%	16.62%	-38.78%
Cost Of Revenue	$4.251M	$14.65M	$4.060M
YoY Change	4.7%	-11.1%	-22.37%
Gross Profit	$2.185M	$10.26M	$1.277M
YoY Change	71.1%	110.07%	-63.36%
Gross Profit Margin	33.95%	41.21%	23.94%
Selling, General & Admin	$2.837M	$8.925M	$2.090M
YoY Change	35.74%	-7.72%	-44.12%
% of Gross Profit	129.84%	86.95%	163.66%
Research & Development	$313.0K	$1.130M	$300.0K
YoY Change	4.33%	-11.72%	-14.29%
% of Gross Profit	14.32%	11.01%	23.49%
Depreciation & Amortization	$650.0K	$2.784M	$690.0K
YoY Change	-5.8%	3.49%	0.0%
% of Gross Profit	29.75%	27.12%	54.03%
Operating Expenses	$3.150M	$10.06M	$2.380M
YoY Change	32.35%	-8.19%	-41.81%
Operating Profit	-$965.0K	$209.0K	-$1.109M
YoY Change	-12.98%	-103.45%	83.0%
Interest Expense	-$17.00K	$49.00K	-$10.00K
YoY Change	70.0%	-34.67%
% of Operating Profit		23.44%
Other Income/Expense, Net		-$1.030M
YoY Change		635.71%
Pretax Income	-$2.057M	-$821.0K	-$1.120M
YoY Change	83.66%	-86.77%	86.67%
Income Tax	-$436.0K	-$156.0K	-$580.0K
% Of Pretax Income
Net Earnings	-$1.621M	-$665.0K	-$543.0K
YoY Change	198.53%	-82.77%	2.45%
Net Earnings / Revenue	-25.19%	-2.67%	-10.18%
Basic Earnings Per Share		-$0.12	-$0.10
Diluted Earnings Per Share	-$291.0K	-$0.12	-$0.10
COMMON SHARES
Basic Shares Outstanding	5.542M	5.549M	5.526M
Diluted Shares Outstanding		5.549M

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.992M	$1.992M	$2.830M
YoY Change	-29.61%	-29.61%	-61.13%
Cash & Equivalents	$1.992M	$1.992M	$2.833M
Short-Term Investments
Other Short-Term Assets	$1.499M	$1.499M	$910.0K
YoY Change	64.73%	64.73%	-49.16%
Inventory
Prepaid Expenses
Receivables	$4.116M	$4.116M	$3.356M
Other Receivables	$2.678M	$2.678M	$2.490M
Total Short-Term Assets	$10.29M	$10.29M	$9.598M
YoY Change	7.16%	7.14%	-25.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.691M	$10.24M	$9.231M
YoY Change	-27.52%	-24.24%	-15.02%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$864.0K	$324.0K	$888.0K
YoY Change	-2.7%	70.53%	-5.83%
Total Long-Term Assets	$11.27M	$11.27M	$14.41M
YoY Change	-21.78%	-21.76%	-1.87%
TOTAL ASSETS
Total Short-Term Assets	$10.29M	$10.29M	$9.598M
Total Long-Term Assets	$11.27M	$11.27M	$14.41M
Total Assets	$21.55M	$21.55M	$24.00M
YoY Change	-10.21%	-10.2%	-12.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$994.0K	$994.0K	$577.0K
YoY Change	72.27%	71.38%	-6.48%
Accrued Expenses	$3.188M	$3.972M	$1.801M
YoY Change	77.01%	48.76%	-49.65%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$664.0K	$664.0K	$688.0K
YoY Change	-3.49%	-3.77%	1.47%
Total Short-Term Liabilities	$5.830M	$5.830M	$3.941M
YoY Change	47.93%	47.97%	-32.46%
LONG-TERM LIABILITIES
Long-Term Debt	$599.0K	$599.0K	$3.444M
YoY Change	-82.61%	-82.59%	76.52%
Other Long-Term Liabilities	$2.880M	$2.880M	$3.900M
YoY Change	-26.15%	-26.15%	63.87%
Total Long-Term Liabilities	$599.0K	$3.479M	$3.444M
YoY Change	-82.61%	-52.6%	76.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.830M	$5.830M	$3.941M
Total Long-Term Liabilities	$599.0K	$3.479M	$3.444M
Total Liabilities	$9.309M	$9.309M	$11.49M
YoY Change	-18.99%	-18.98%	7.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.550M		-$8.606M
YoY Change	10.97%		129.25%
Common Stock	$33.51M		$32.83M
YoY Change	2.06%		1.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$10.08M		$10.08M
YoY Change	0.0%		0.0%
Treasury Stock Shares	$668.0K		$668.0K
Shareholders Equity	$12.24M	$12.24M	$12.51M
YoY Change
Total Liabilities & Shareholders Equity	$21.55M	$21.55M	$24.00M
YoY Change	-10.21%	-10.2%	-12.81%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$1.621M	-$665.0K	-$543.0K
YoY Change	198.53%	-82.77%	2.45%
Depreciation, Depletion And Amortization	$650.0K	$2.784M	$690.0K
YoY Change	-5.8%	3.49%	0.0%
Cash From Operating Activities	$565.0K	$414.0K	$1.140M
YoY Change	-50.44%	-110.14%	20.0%
INVESTING ACTIVITIES
Capital Expenditures	-$30.00K	$182.0K	$70.00K
YoY Change	-142.86%	-81.63%	-112.5%
Acquisitions
YoY Change
Other Investing Activities	$4.000K	-$38.00K	-$20.00K
YoY Change	-120.0%	-129.23%	100.0%
Cash From Investing Activities	-$26.00K	-$220.0K	$50.00K
YoY Change	-152.0%	-74.36%	-108.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$68.00K
YoY Change		655.56%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-515.0K	-$1.035M	-170.0K
YoY Change	202.94%	-306.59%	-153.13%
NET CHANGE
Cash From Operating Activities	565.0K	$414.0K	1.140M
Cash From Investing Activities	-26.00K	-$220.0K	50.00K
Cash From Financing Activities	-515.0K	-$1.035M	-170.0K
Net Change In Cash	24.00K	-$841.0K	1.020M
YoY Change	-97.65%	-81.1%	43.66%
FREE CASH FLOW
Cash From Operating Activities	$565.0K	$414.0K	$1.140M
Capital Expenditures	-$30.00K	$182.0K	$70.00K
Free Cash Flow	$595.0K	$232.0K	$1.070M
YoY Change	-44.39%	-104.57%	-29.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Auditor Location AuditorLocation	Boston, Massachusetts
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	89000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	37000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19659000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16937000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	873000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	873000
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	348000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6257000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6205000
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5589000
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5537000
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	668000
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	668000
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10082000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10082000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9550000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8606000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1634000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1634000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	209000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-6066000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	2998000	USD
CY2021	pmd	Other Nonoperating Expense Settlement OtherNonoperatingExpenseSettlement	3150000	USD
CY2020	pmd	Other Nonoperating Expense Settlement OtherNonoperatingExpenseSettlement	-0	USD
CY2019	pmd	Other Nonoperating Expense Settlement OtherNonoperatingExpenseSettlement	-0	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	61000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	140000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-58000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1030000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-140000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	58000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-821000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6206000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3056000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-156000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2347000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1514000	USD
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-10000	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-225000	USD
CY2019	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	33000	USD
CY2019	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.72
CY2019	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	3970000	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-225000	USD
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	9000	USD
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
CY2020	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	993000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-3859000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-10000	USD
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	72000	USD
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
CY2021	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	279000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-665000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-3859000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	1542000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2181000	USD
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	371000	USD
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	339000	USD
CY2019	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	405000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	760000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-424000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1049000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	585000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-392000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-64000	USD
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	183000	USD
CY2020	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	2013000	USD
CY2019	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	482000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	417000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-281000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-494000	USD
CY2021	pmd	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-1078000	USD
CY2020	pmd	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-914000	USD
CY2019	pmd	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	0	USD
CY2021	pmd	Increase Decrease In Accrued Expenses And Accrued Income Taxes IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes	1387000	USD
CY2020	pmd	Increase Decrease In Accrued Expenses And Accrued Income Taxes IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes	-1776000	USD
CY2019	pmd	Increase Decrease In Accrued Expenses And Accrued Income Taxes IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes	-671000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	414000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4083000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4309000	USD
CY2021	pmd	Payments For Proceeds From Other Assets PaymentsForProceedsFromOtherAssets	38000	USD
CY2020	pmd	Payments For Proceeds From Other Assets PaymentsForProceedsFromOtherAssets	7000	USD
CY2019	pmd	Payments For Proceeds From Other Assets PaymentsForProceedsFromOtherAssets	56000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	182000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	991000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1677000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-220000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-858000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2077000	USD
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	279000	USD
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	993000	USD
CY2019	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3970000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-68000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-9000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-33000	USD
CY2021	pmd	Payments Of Equipment Financing PaymentsOfEquipmentFinancing	688000	USD
CY2020	pmd	Payments Of Equipment Financing PaymentsOfEquipmentFinancing	678000	USD
CY2019	pmd	Payments Of Equipment Financing PaymentsOfEquipmentFinancing	415000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1035000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	501000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3002000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-10000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-170000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-841000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4450000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3214000	USD
CY2020Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	USD
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	3000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	30000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	131000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-2006000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1478000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	84000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-2000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	54000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	215000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-2008000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1880000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-704000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-13000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-139000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	333000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-326000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-227000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-371000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-339000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-366000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-156000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2347000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1514000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	414000	USD
CY2021Q4	pmd	Deferred Tax Liabilities Excess Of Tax Over Book Depreciation And Amortization DeferredTaxLiabilitiesExcessOfTaxOverBookDepreciationAndAmortization	1249000	USD
CY2020Q4	pmd	Deferred Tax Liabilities Excess Of Tax Over Book Depreciation And Amortization DeferredTaxLiabilitiesExcessOfTaxOverBookDepreciationAndAmortization	1775000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	61000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	48000	USD
CY2021Q4	pmd	Deferred Tax Liabilities Operating Lease DeferredTaxLiabilitiesOperatingLease	837000	USD
CY2020Q4	pmd	Deferred Tax Liabilities Operating Lease DeferredTaxLiabilitiesOperatingLease	1015000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2147000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2838000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2833000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4116000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3356000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1499000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	160000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	211000	USD
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	29000
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	457000	USD
CY2021	us-gaap	Interest Income Other InterestIncomeOther	0	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1992000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	914000	USD
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2678000	USD
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2495000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	10285000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	9598000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	4521000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	4422000	USD
CY2021Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2195000	USD
CY2020Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2139000	USD
CY2021Q4	pmd	Laboratory Equipment LaboratoryEquipment	16005000	USD
CY2020Q4	pmd	Laboratory Equipment LaboratoryEquipment	15978000	USD
CY2021Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3629000	USD
CY2020Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3629000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	26350000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	26168000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6691000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9231000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	864000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	888000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	160000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3552000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4286000	USD
CY2021Q4	us-gaap	Assets Assets	21552000	USD
CY2020Q4	us-gaap	Assets Assets	24003000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	994000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	577000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3188000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1801000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	664000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	688000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	984000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	875000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5830000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3941000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	599000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3444000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	211000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2880000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3895000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	9309000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	11491000	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	31000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	31000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	33478000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	32803000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12243000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	12512000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21552000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24003000	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	24909000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	21360000	USD
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	37678000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14645000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16474000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	21234000	USD
CY2021	us-gaap	Gross Profit GrossProfit	10264000	USD
CY2020	us-gaap	Gross Profit GrossProfit	4886000	USD
CY2019	us-gaap	Gross Profit GrossProfit	16444000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6126000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6095000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7221000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2799000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3577000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4658000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1130000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1280000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1567000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	10055000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	10952000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	13446000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2181000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-665000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-3859000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	1542000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-665000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3869000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1317000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.70
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.70
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5549000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5524000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5514000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5549000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5524000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5525000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	18747000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	759000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	1542000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	16820000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	563000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	12512000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	4000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	743000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12243000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-665000	USD
CY2021	pmd	Depreciation And Amortization Excluding Rou Asset Amortization DepreciationAndAmortizationExcludingRouAssetAmortization	2784000	USD
CY2020	pmd	Depreciation And Amortization Excluding Rou Asset Amortization DepreciationAndAmortizationExcludingRouAssetAmortization	2691000	USD
CY2019	pmd	Depreciation And Amortization Excluding Rou Asset Amortization DepreciationAndAmortizationExcludingRouAssetAmortization	2914000	USD
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	906000	USD
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	935000	USD
CY2019	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-94000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-0	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-0	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-0	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-33000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	743000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	563000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	759000	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	140000	USD
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	3810000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2833000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7283000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4069000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1992000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2833000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7283000	USD
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	405000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	249000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	2898000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	50000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	75000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	59000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1151000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	1038000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	1199000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	172000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2346000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4363000	USD
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	241000	USD
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	1882000	USD
CY2021	pmd	Income Tax Benefit Cares Act IncomeTaxBenefitCARESAct	2600000	USD
CY2020	pmd	Income Tax Benefit Cares Act IncomeTaxBenefitCARESAct	200000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2000000.0	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -18pt; text-align: justify;"/> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-align: justify;"><b><i>Estimates</i></b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -18pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-indent: 15pt; text-align: justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates, including those related to bad debts, long-lived asset lives, income tax valuation and share based compensation, and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Changes in estimates are recorded in the period in which they become known.</p>
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2700000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2600000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2900000	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	24909000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	21360000	USD
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	37678000	USD
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5524000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5525000
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -18pt; text-align: justify;"/> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-align: justify;"><b><i>Concentration of Credit Risk and Off-Balance Sheet Risk</i></b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -18pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-indent: 15pt; text-align: justify;">The Company has <em style="font: inherit;">no</em> significant off-balance-sheet risk such as foreign exchange contracts, option contracts, or other foreign hedging arrangements. Financial instruments that potentially subject the Company to concentrations of credit risk are principally cash and accounts receivable. The Company’s policy is to place its cash in high quality financial institutions. At time, these deposits <em style="font: inherit;"> may </em>exceed or be exempt from federally insured limits. The Company does <em style="font: inherit;">not</em> believe significant credit risk exists with respect to these institutions. Concentration of credit risk with respect to accounts receivable is limited to certain customers to whom the Company makes substantial sales. To reduce risk, the Company routinely assesses the financial strength of its customers and, as a consequence, believes that its accounts receivable credit risk exposure is limited. The Company maintains an allowance for potential credit losses but historically has <em style="font: inherit;">not</em> experienced any significant losses related to individual customers or groups of customers in any particular industry or geographic area. The Company does <em style="font: inherit;">not</em> require collateral.</p>
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	743000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	563000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	759000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5549000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5524000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5514000
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2019	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5549000
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	545000
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	588000
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	357000
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	37000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	45000	USD
CY2021	pmd	Provision For Recoveries Of Doubtful Accounts ProvisionForRecoveriesOfDoubtfulAccounts	55000	USD
CY2020	pmd	Provision For Recoveries Of Doubtful Accounts ProvisionForRecoveriesOfDoubtfulAccounts	22000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	89000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	37000	USD
CY2021Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	507000	USD
CY2020Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	315000	USD
CY2021Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	373000	USD
CY2020Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	379000	USD
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	200000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	4000	USD
CY2021Q4	pmd	Accrued Shipping Current AccruedShippingCurrent	488000	USD
CY2020Q4	pmd	Accrued Shipping Current AccruedShippingCurrent	511000	USD
CY2021Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	1150000	USD
CY2020Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	0	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	470000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	592000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3188000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1801000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.104	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.044	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.045	pure
CY2021	pmd	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	0.476	pure
CY2020	pmd	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	0.000	pure
CY2019	pmd	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	-0.081	pure
CY2021	pmd	Effective Income Tax Rate Reconciliation Nondeductible Expense Benefit Sharebased Compensation Cost Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseBenefitSharebasedCompensationCostPercent	0.014	pure
CY2020	pmd	Effective Income Tax Rate Reconciliation Nondeductible Expense Benefit Sharebased Compensation Cost Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseBenefitSharebasedCompensationCostPercent	-0.004	pure
CY2019	pmd	Effective Income Tax Rate Reconciliation Nondeductible Expense Benefit Sharebased Compensation Cost Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseBenefitSharebasedCompensationCostPercent	0.013	pure
CY2021	pmd	Effective Income Tax Rate Reconciliation Tax Credit Expense Research Percent EffectiveIncomeTaxRateReconciliationTaxCreditExpenseResearchPercent	-0.000	pure
CY2020	pmd	Effective Income Tax Rate Reconciliation Tax Credit Expense Research Percent EffectiveIncomeTaxRateReconciliationTaxCreditExpenseResearchPercent	-0.016	pure
CY2019	pmd	Effective Income Tax Rate Reconciliation Tax Credit Expense Research Percent EffectiveIncomeTaxRateReconciliationTaxCreditExpenseResearchPercent	0.047	pure
CY2021	pmd	Income Tax Reconciliation Foreign Income Tax Witholdings IncomeTaxReconciliationForeignIncomeTaxWitholdings	-0.109	pure
CY2020	pmd	Income Tax Reconciliation Foreign Income Tax Witholdings IncomeTaxReconciliationForeignIncomeTaxWitholdings	-0.022	pure
CY2019	pmd	Income Tax Reconciliation Foreign Income Tax Witholdings IncomeTaxReconciliationForeignIncomeTaxWitholdings	0.445	pure
CY2021	pmd	Effective Income Tax Rate Reconciliation Change In Tax Rate For Carryback Claim EffectiveIncomeTaxRateReconciliationChangeInTaxRateForCarrybackClaim	0.000	pure
CY2020	pmd	Effective Income Tax Rate Reconciliation Change In Tax Rate For Carryback Claim EffectiveIncomeTaxRateReconciliationChangeInTaxRateForCarrybackClaim	0.134	pure
CY2019	pmd	Effective Income Tax Rate Reconciliation Change In Tax Rate For Carryback Claim EffectiveIncomeTaxRateReconciliationChangeInTaxRateForCarrybackClaim	0.000	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.505	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.000	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.000	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.190	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.378	pure
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.495	pure
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	21000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	9000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	129000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	112000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	325000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	265000	USD
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1083000	USD
CY2020Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1005000	USD
CY2021Q4	pmd	Deferred Tax Assets Operating Lease DeferredTaxAssetsOperatingLease	944000	USD
CY2020Q4	pmd	Deferred Tax Assets Operating Lease DeferredTaxAssetsOperatingLease	1130000	USD
CY2021Q4	pmd	Deferred Tax Assets Ppp Loan Expenses DeferredTaxAssetsPPPLoanExpenses	0	USD
CY2020Q4	pmd	Deferred Tax Assets Ppp Loan Expenses DeferredTaxAssetsPPPLoanExpenses	9000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	219000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	97000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2721000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2627000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2627000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2307000	USD
CY2020	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	115000	USD
CY2019Q2	us-gaap	Share Price SharePrice	2.99
CY2020Q4	us-gaap	Share Price SharePrice	1.13
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.47
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.40
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	604000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.31
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.07
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.47
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	574000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.23
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M6D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	100000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	464000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	15.12
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y8M12D
CY2021Q4	us-gaap	Share Price SharePrice	7.02
CY2020Q4	us-gaap	Share Price SharePrice	5.09
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	296000	USD
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	274000	USD
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	223000	USD
CY2021	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	501000	USD
CY2019	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	144000	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1200000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y10M24D
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	198000	USD
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	262000	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	1100000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	1100000	USD
CY2019	us-gaap	Operating Lease Expense OperatingLeaseExpense	1200000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.039	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	1100000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	1100000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1117000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1118000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1034000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	592000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	460000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4321000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3864000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	984000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2880000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3864000	USD
CY2021	us-gaap	Interest Expense InterestExpense	49000	USD
CY2020	us-gaap	Interest Expense InterestExpense	75000	USD
CY2019	us-gaap	Interest Expense InterestExpense	59000	USD
CY2020	us-gaap	Interest Income Other InterestIncomeOther	0	USD
CY2019	us-gaap	Interest Income Other InterestIncomeOther	134000	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	24909000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	21360000	USD
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	37678000	USD

Files In Submission

Name	View Source	Status
0001171843-22-002192-index-headers.html	Edgar Link	pending
0001171843-22-002192-index.html	Edgar Link	pending
0001171843-22-002192.txt	Edgar Link	pending
0001171843-22-002192-xbrl.zip	Edgar Link	pending
ex_349663.htm	Edgar Link	pending
ex_349664.htm	Edgar Link	pending
ex_349665.htm	Edgar Link	pending
ex_349666.htm	Edgar Link	pending
ex_349667.htm	Edgar Link	pending
ex_349668.htm	Edgar Link	pending
ex_349669.htm	Edgar Link	pending
ex_351596.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pmd-20211231.xsd	Edgar Link	pending
pmd-20211231_cal.xml	Edgar Link	unprocessable
pmd-20211231_def.xml	Edgar Link	unprocessable
pmd-20211231_lab.xml	Edgar Link	unprocessable
pmd-20211231_pre.xml	Edgar Link	unprocessable
pmd20211231_10k.htm	Edgar Link	pending
pmd20211231_10kimg003.jpg	Edgar Link	pending
pmd20211231_10k_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PMDI
PSYCHEMEDICS CORP Stock $pmdi

2021 Q4 Form 10-K Financial Statement

#000117184322002192 Filed on March 30, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMDI PSYCHEMEDICS CORP Stock $pmdi

2021 Q4 Form 10-K Financial Statement

#000117184322002192 Filed on March 30, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMDI
PSYCHEMEDICS CORP Stock $pmdi